drugset / Trial / NCT05400395
Clinical Trial for GNX80 in Intermittent Claudication
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase 4, randomized clinical trial to evaluate whether GNX80 vs. placebo, prescribed for 6 months to patients with Intermittent Claudication(IC) would lead to an improvement in the walking distance.
Timeline
- Start
- 2022-09-05
- Primary completion
- 2024-03
- Completion
- 2024-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GNX80 | Unknown | 80 mg | Oral |